Primary Site >> Biliary tract Cancer

Gene >> BRCA1

  • 2014
  • 2015
  • 2016
  • 2017
  • 2018
Ref: New routes to targeted therapy of intrahepatic cholangiocarcinomas revealed by next-generation sequencing.
PMID: 24563076
Ref: CRISPR/Cas9 somatic multiplex-mutagenesis for high-throughput functional cancer genomics in mice.
PMID: 26508638
Ref: Analysis of Founder Mutations in Rare Tumors Associated With Hereditary Breast/Ovarian Cancer Reveals a Novel Association of BRCA2 Mutations with Ampulla of Vater Carcinomas.
PMID: 27532258
Ref: Response of BRCA1-mutated gallbladder cancer to olaparib: A case report.
PMID: 28028375
Ref: Overall Survival and Clinical Characteristics of BRCA-Associated Cholangiocarcinoma: A Multicenter Retrospective Study.
PMID: 28487467
Ref: Somatic BRCA1-associated protein 1 (BAP1) loss is an early and rare event in esophageal adenocarcinoma.
PMID: 28781790
Ref: Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations.
PMID: 29360550
Ref: Genotyping and mRNA profiling reveal actionable molecular targets in biliary tract cancers.
PMID: 29416916
Ref: Hybrid Capture-Based Tumor Sequencing and Copy Number Analysis to Confirm Origin of Metachronous Metastases in BRCA1-Mutant Cholangiocarcinoma Harboring a Novel YWHAZ-BRAF Fusion.
PMID: 29622700
Ref: New developments in systemic therapy for advanced biliary tract cancer.
PMID: 29893894
Ref: Treatment with olaparib monotherapy for BRCA2-mutated refractory intrahepatic cholangiocarcinoma: a case report.
PMID: 30271179